EMPA-REG: Glucose excretion and lipid mobilization – not storage – saves lives
- 23 February 2016
- journal article
- Published by Elsevier BV in Journal of Diabetes and its Complications
- Vol. 30 (4), 753
- https://doi.org/10.1016/j.jdiacomp.2016.02.015
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Assessment of myocardial metabolic flexibility and work efficiency in human type 2 diabetes using 16-[18F]fluoro-4-thiapalmitate, a novel PET fatty acid tracerAmerican Journal of Physiology-Endocrinology and Metabolism, 2016
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 DiabetesNew England Journal of Medicine, 2015
- A Randomized Trial of Intensive versus Standard Blood-Pressure ControlNew England Journal of Medicine, 2015
- The EMPA-REG study: What has it told us? A diabetologist’s perspectiveJournal of Diabetes and its Complications, 2015
- EMPA-REG – the “diuretic hypothesis”Journal of Diabetes and its Complications, 2015
- Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patientsJCI Insight, 2014
- Decreased long‐chain fatty acid oxidation impairs postischemic recovery of the insulin‐resistant rat heartThe FASEB Journal, 2013
- Similar patterns of myocardial metabolism and perfusion in patients with type 2 diabetes and heart disease of ischaemic and non-ischaemic originDiabetologia, 2012
- Free Fatty Acid Depletion Acutely Decreases Cardiac Work and Efficiency in Cardiomyopathic Heart FailureCirculation, 2006